Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212
Jessica Wagner
1
,
Christina Leah Kline
1
,
Marie D. Ralff
1
,
Avital Lev
1
,
Amriti Lulla
1
,
Lanlan Zhou
1
,
Gary L. Olson
2
,
Bhaskara Rao Nallaganchu
2
,
Cyril H Benes
3
,
Joshua E. Allen
4
,
Varun V. Prabhu
4
,
Martin Stogniew
4
,
Wolfgang Oster
4
,
Wafik S. El-Deiry
1
2
Provid Pharmaceuticals, Monmouth Junction, NJ, USA
|
3
Massachusettes General Hospital, Boston, MA, USA
|
4
Oncoceutics, Inc., Philadelphia, PA, USA
|
Publication type: Journal Article
Publication date: 2017-09-22
scimago Q1
wos Q3
SJR: 0.937
CiteScore: 7.9
Impact factor: 3.4
ISSN: 15384101, 15514005
PubMed ID:
28489985
Molecular Biology
Cell Biology
Developmental Biology
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
4
5
|
|
|
Journal of Medicinal Chemistry
5 publications, 7.94%
|
|
|
Frontiers in Pharmacology
3 publications, 4.76%
|
|
|
Clinical Cancer Research
3 publications, 4.76%
|
|
|
Cancers
2 publications, 3.17%
|
|
|
Frontiers in Oncology
2 publications, 3.17%
|
|
|
Biochemical Pharmacology
2 publications, 3.17%
|
|
|
Neoplasia
2 publications, 3.17%
|
|
|
Cell Cycle
2 publications, 3.17%
|
|
|
Neuro-Oncology
2 publications, 3.17%
|
|
|
Current Medicinal Chemistry
1 publication, 1.59%
|
|
|
Molecules
1 publication, 1.59%
|
|
|
Biomolecules
1 publication, 1.59%
|
|
|
Pharmaceuticals
1 publication, 1.59%
|
|
|
Frontiers in Pediatrics
1 publication, 1.59%
|
|
|
Scientific Reports
1 publication, 1.59%
|
|
|
Journal of Experimental and Clinical Cancer Research
1 publication, 1.59%
|
|
|
Leukemia
1 publication, 1.59%
|
|
|
Signal Transduction and Targeted Therapy
1 publication, 1.59%
|
|
|
Journal of Pharmaceutical and Biomedical Analysis
1 publication, 1.59%
|
|
|
Cancer Cell
1 publication, 1.59%
|
|
|
Bioorganic and Medicinal Chemistry Letters
1 publication, 1.59%
|
|
|
Antiviral Research
1 publication, 1.59%
|
|
|
Cancer Biology and Therapy
1 publication, 1.59%
|
|
|
Frontiers in Cell and Developmental Biology
1 publication, 1.59%
|
|
|
Drug Discovery Today
1 publication, 1.59%
|
|
|
British Journal of Pharmacology
1 publication, 1.59%
|
|
|
Pharmacology Research and Perspectives
1 publication, 1.59%
|
|
|
ACS Chemical Biology
1 publication, 1.59%
|
|
|
Journal of Natural Products
1 publication, 1.59%
|
|
|
1
2
3
4
5
|
Publishers
|
2
4
6
8
10
|
|
|
Elsevier
10 publications, 15.87%
|
|
|
MDPI
7 publications, 11.11%
|
|
|
Frontiers Media S.A.
7 publications, 11.11%
|
|
|
Springer Nature
7 publications, 11.11%
|
|
|
American Chemical Society (ACS)
7 publications, 11.11%
|
|
|
American Association for Cancer Research (AACR)
6 publications, 9.52%
|
|
|
Taylor & Francis
5 publications, 7.94%
|
|
|
Cold Spring Harbor Laboratory
4 publications, 6.35%
|
|
|
Oxford University Press
3 publications, 4.76%
|
|
|
Wiley
2 publications, 3.17%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 1.59%
|
|
|
Royal Society of Chemistry (RSC)
1 publication, 1.59%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 1.59%
|
|
|
American Society for Clinical Investigation
1 publication, 1.59%
|
|
|
2
4
6
8
10
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
63
Total citations:
63
Citations from 2024:
18
(28%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Wagner J. et al. Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212 // Cell Cycle. 2017. Vol. 16. No. 19. pp. 1790-1799.
GOST all authors (up to 50)
Copy
Wagner J., Kline C. L., Ralff M. D., Lev A., Lulla A., Zhou L., Olson G. L., Nallaganchu B. R., Benes C. H., Allen J. E., Prabhu V. V., Stogniew M., Oster W., El-Deiry W. S. Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212 // Cell Cycle. 2017. Vol. 16. No. 19. pp. 1790-1799.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1080/15384101.2017.1325046
UR - https://doi.org/10.1080/15384101.2017.1325046
TI - Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212
T2 - Cell Cycle
AU - Wagner, Jessica
AU - Kline, Christina Leah
AU - Ralff, Marie D.
AU - Lev, Avital
AU - Lulla, Amriti
AU - Zhou, Lanlan
AU - Olson, Gary L.
AU - Nallaganchu, Bhaskara Rao
AU - Benes, Cyril H
AU - Allen, Joshua E.
AU - Prabhu, Varun V.
AU - Stogniew, Martin
AU - Oster, Wolfgang
AU - El-Deiry, Wafik S.
PY - 2017
DA - 2017/09/22
PB - Taylor & Francis
SP - 1790-1799
IS - 19
VL - 16
PMID - 28489985
SN - 1538-4101
SN - 1551-4005
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2017_Wagner,
author = {Jessica Wagner and Christina Leah Kline and Marie D. Ralff and Avital Lev and Amriti Lulla and Lanlan Zhou and Gary L. Olson and Bhaskara Rao Nallaganchu and Cyril H Benes and Joshua E. Allen and Varun V. Prabhu and Martin Stogniew and Wolfgang Oster and Wafik S. El-Deiry},
title = {Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212},
journal = {Cell Cycle},
year = {2017},
volume = {16},
publisher = {Taylor & Francis},
month = {sep},
url = {https://doi.org/10.1080/15384101.2017.1325046},
number = {19},
pages = {1790--1799},
doi = {10.1080/15384101.2017.1325046}
}
Cite this
MLA
Copy
Wagner, Jessica, et al. “Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212.” Cell Cycle, vol. 16, no. 19, Sep. 2017, pp. 1790-1799. https://doi.org/10.1080/15384101.2017.1325046.